Historically, evidence-based treatment has followed the latent disease model, which emphasizes using specific protocols tied to diagnoses. Today, field continues move towards an individual approach with models of based on change processes. Here, we describe Process-Based Therapy (PBT), a new way thinking that is moving away from nomothetic studies diagnosis-driven interventions toward recognize...

despite diagnostic, preventive and therapeutic advances, growing incidence of cancer and high rate of mortality among patients affected by specific cancer types indicate current clinical measures are not ideally useful in eradicating cancer. chemoresistance and subsequent disease relapse are believed to be mainly driven by the cell-molecular heterogeneity of human tumors that necessitates perso...